Target intelligence / Profile preview

Adenosine triphosphate (ATP) (ATP)

Target
ATP
Molecular classification
Nucleotide, Metabolite, Energy carrier, Other
01

Overview

Adenosine triphosphate (ATP) is the primary energy currency in sperm cells, providing the chemical energy necessary for flagellar propulsion, capacitation, and the acrosome reaction required for fertilization. In sperm, ATP is generated through two main metabolic pathways: glycolysis, which occurs in the fibrous sheath of the flagellum, and oxidative phosphorylation, which takes place in the mitochondria of the midpiece. The maintenance of high ATP levels is a critical determinant of sperm motility, and its depletion is a hallmark of asthenozoospermia and male infertility. In the context of drug development, "Sperm cell ATP" is often cited as a metabolic target for non-hormonal male contraceptives, where compounds like gossypol or specific mitochondrial inhibitors are used to reduce ATP production and immobilize sperm. Conversely, strategies to boost ATP levels or enhance its utilization are explored for treating male factor infertility. While ATP itself is a metabolite rather than a traditional protein target, the enzymes and transporters that regulate its concentration—such as sperm-specific glyceraldehyde-3-phosphate dehydrogenase (GAPDS) or mitochondrial respiratory complexes—serve as the actual druggable targets for therapeutic intervention.

Other names
Sperm ATPAdenosine-5'-triphosphateSperm cell energy sourceIntracellular ATP
02

Mechanism of action

Modulation of intracellular energy levels by inhibiting or uncoupling mitochondrial oxidative phosphorylation or inhibiting sperm-specific glycolytic enzymes to deplete the ATP pool required for motility.

03

Biological functions

Energy metabolismSperm motilityFlagellar beatingCapacitationAcrosome reactionSignal transduction
04

Disease associations

InfertilityAsthenozoospermiaMitochondrial dysfunction
05

Safety considerations

Lack of tissue specificity for general metabolic inhibitorsPotential for systemic mitochondrial toxicityOff-target effects on high-energy tissues such as the heart, brain, and skeletal muscleIrreversibility of certain metabolic toxins
06

Interacting drugs

Gossypol

6 more in the full profile.

07

Biomarkers

Intracellular ATP concentrationSperm motility (CASA)Oxygen consumption rate (OCR)Mitochondrial membrane potential (ΔΨm)

Beyond the preview

Go deeper on Adenosine triphosphate (ATP) (ATP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenosine triphosphate (ATP) (ATP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call